Eder U - Search Results

1

Olanzapine-induced hyperglycemia: role of humoral insulin resistance-inducing factors.

Laimer M, Ebenbichler CF, Kranebitter M, Eder U, Mangweth B, Weiss E, Hofer A, Hummer M, Kemmler G, Lechleitner M, Patsch JR, Fleischhacker WW. Laimer M, et al. Among authors: eder u. J Clin Psychopharmacol. 2005 Apr;25(2):183-5. doi: 10.1097/01.jcp.0000155827.05327.88. J Clin Psychopharmacol. 2005. PMID: 15738752 No abstract available.

2

Olanzapine induces insulin resistance: results from a prospective study.

Ebenbichler CF, Laimer M, Eder U, Mangweth B, Weiss E, Hofer A, Hummer M, Kemmler G, Lechleitner M, Patsch JR, Fleischhacker WW. Ebenbichler CF, et al. Among authors: eder u. J Clin Psychiatry. 2003 Dec;64(12):1436-9. doi: 10.4088/jcp.v64n1206. J Clin Psychiatry. 2003. PMID: 14728104 Clinical Trial.

3

Association of olanzapine-induced weight gain with an increase in body fat.

Eder U, Mangweth B, Ebenbichler C, Weiss E, Hofer A, Hummer M, Kemmler G, Lechleitner M, Fleischhacker WW. Eder U, et al. Am J Psychiatry. 2001 Oct;158(10):1719-22. doi: 10.1176/appi.ajp.158.10.1719. Am J Psychiatry. 2001. PMID: 11579009 Clinical Trial.

4

Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication.

Rettenbacher MA, Hofer A, Eder U, Hummer M, Kemmler G, Weiss EM, Fleischhacker WW. Rettenbacher MA, et al. Among authors: eder u. J Clin Psychiatry. 2004 Sep;65(9):1211-8. doi: 10.4088/jcp.v65n0908. J Clin Psychiatry. 2004. PMID: 15367047

5

Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.

Hofer A, Kemmler G, Eder U, Edlinger M, Hummer M, Fleischhacker WW. Hofer A, et al. Among authors: eder u. J Clin Psychiatry. 2004 Jul;65(7):932-9. J Clin Psychiatry. 2004. PMID: 15291682

6

Attitudes toward antipsychotics among outpatient clinic attendees with schizophrenia.

Hofer A, Kemmler G, Eder U, Honeder M, Hummer M, Fleischhacker WW. Hofer A, et al. Among authors: eder u. J Clin Psychiatry. 2002 Jan;63(1):49-53. doi: 10.4088/jcp.v63n0110. J Clin Psychiatry. 2002. PMID: 11838626

7

Attitudes of patients with schizophrenia toward placebo-controlled clinical trials.

Hummer M, Holzmeister R, Kemmler G, Eder U, Hofer A, Kurzthaler I, Oehl M, Weiss E, Fleischhacker WW. Hummer M, et al. Among authors: eder u. J Clin Psychiatry. 2003 Mar;64(3):277-81. doi: 10.4088/jcp.v64n0308. J Clin Psychiatry. 2003. PMID: 12716268

8

Levels and molecular properties of secretoneurin-immunoreactivity in the serum and urine of control and neuroendocrine tumor patients.

Ischia R, Gasser RW, Fischer-Colbrie R, Eder U, Pagani A, Cubeddu LX, Lovisetti-Scamihorn P, Finkenstedt G, Laslop A, Winkler H. Ischia R, et al. Among authors: eder u. J Clin Endocrinol Metab. 2000 Jan;85(1):355-60. doi: 10.1210/jcem.85.1.6314. J Clin Endocrinol Metab. 2000. PMID: 10634410 Clinical Trial.

9

Processing of secretogranin II by prohormone convertases: importance of PC1 in generation of secretoneurin.

Hoflehner J, Eder U, Laslop A, Seidah NG, Fischer-Colbrie R, Winkler H. Hoflehner J, et al. Among authors: eder u. FEBS Lett. 1995 Mar 6;360(3):294-8. doi: 10.1016/0014-5793(95)00127-u. FEBS Lett. 1995. PMID: 7883050 Free article.

10

Localization and axotomy-induced regulation of the peptide secretoneurin in the rat superior cervical ganglion.

Klimaschewski L, Kroesen S, Eder U, Leitner B, Fischer-Colbrie R. Klimaschewski L, et al. Among authors: eder u. Eur J Neurosci. 1996 Sep;8(9):1953-64. doi: 10.1111/j.1460-9568.1996.tb01339.x. Eur J Neurosci. 1996. PMID: 8921286

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters